A Phase I Study of Pegylated Liposomal Doxorubicin Hydrochloride (Caelyx™) in Combination with Cyclophosphamide and Vincristine as Second-Line Treatment of Patients with Small-Cell Lung Cancer
Natasha B. Leighl, Ronald L. Burkes, Janet Dancey, Pedro García López, Brian P. Higgins, P L Walde, Leona Rudinskas, Yasmin Rahim, A. Rodgers, Gregory R. Pond, Frances A. Shepherd